Perimenopause affects fertility through declining ovarian reserve and fluctuating hormones, often linked with low AMH. Early awareness enables timely fertility choices like IVF or egg freezing. Treatments including HRT support both conception and long-term health, helping women navigate this transition confidently.
By Mr Ed Coats, Consultant in Reproductive Medicine and Menopause Care
At The Evewell, we meet women at every stage of their reproductive journey. Some come to us in their twenties, planning ahead; many are in their thirties and forties, actively trying to conceive; others are exploring IVF or egg freezing. Increasingly, I also see women who are navigating the often-misunderstood world of perimenopause.
As a fertility doctor and menopause specialist, I know how closely these two areas overlap. Hormones drive both fertility and the menopause transition, and when levels begin to fluctuate, whether earlier than expected or right on time, the effects can be profound.
Understanding perimenopause is not only important for long-term health, but also critical for women with low AMH who are exploring fertility treatments such as IVF. This article aims to connect the dots: what perimenopause really is, how it impacts fertility, why early awareness matters, and how treatments like HRT (hormone replacement therapy) can support women both in their reproductive years and beyond.
Let’s start with definitions.
Rather than a slow, gentle decline in hormones, perimenopause is marked by dramatic rises and falls in oestrogen and progesterone. This is why symptoms can seem to come and go, vary in intensity, and mimic other conditions.
The average age of menopause in the UK is 51. That means perimenopause typically begins in the early to mid-40s, though it can start in the late 30s for some women. By the late 40s, it’s almost statistically certain that hormonal changes are underway.
Every woman is born with a finite number of eggs. Unlike men, who continue to produce sperm throughout their lives, women’s egg supply declines steadily from birth.
As the ovarian reserve diminishes, so do levels of AMH (Anti-Müllerian Hormone), one of the key markers we use in fertility medicine. A low AMH level is often one of the first clues that the ovaries are entering a later stage of function, even if cycles are still regular.
The brain responds by sending stronger hormonal signals (FSH and LH) to the ovaries, trying to stimulate them to release an egg. But with fewer follicles left, the ovaries respond unpredictably. This mismatch between the brain and ovaries creates the erratic hormone swings we see in perimenopause.
Perimenopause is often described as a “zone of chaos” because of the wide-ranging symptoms it can cause. Common signs include:
Not every woman will experience all of these, but for many, the impact on daily life is significant. Importantly, these changes can occur while a woman is still fertile, which brings us to the link between perimenopause and IVF.
In fertility medicine, AMH (Anti-Müllerian Hormone) is one of the most important markers of ovarian reserve. It reflects the number of eggs a woman still has.
For women with low AMH, the window for conceiving naturally is narrower. IVF may be recommended to improve the chances of pregnancy. However, declining ovarian reserve and fluctuating hormones make the process more challenging.
Not at all. Many women in perimenopause still ovulate — sometimes unpredictably, but ovulation does occur. I have seen women with very low AMH achieve successful pregnancies with IVF, donor eggs, or even naturally. But awareness is vital: the earlier you understand your hormonal status, the more options you have.
When we design IVF treatment for women in perimenopause or with low AMH, we adapt protocols to maximise the chances of success.
It’s important to recognise that IVF during perimenopause is not about “fighting biology” — it’s about working with the body in its current state, using medical support where needed.
When most people think of HRT (Hormone Replacement Therapy), they think of it as a treatment for hot flushes after menopause. But in reality, HRT plays a broader role.
For women in perimenopause:
For fertility patients, particularly those with low AMH:
One of the most striking issues in my practice is how few women know about perimenopause before they are in the middle of it. Medical education often stops once reproduction is discussed, leaving decades of female health under-addressed.
Women in their late 30s may be told they are “too young” for perimenopause, even as they struggle with symptoms. Others come for fertility treatment, only to discover that their low AMH and irregular cycles are early signs of ovarian decline.
This lack of awareness costs precious time. For fertility, earlier action can make the difference between having more treatment options or fewer. For health, it means women miss the chance to protect bones, heart and brain when they are most vulnerable.
If you’re in your late 30s or early 40s, trying to conceive, and starting to wonder whether the symptoms you’re experiencing could be linked to perimenopause, the most important step is not to wait. Seek medical advice promptly. A fertility specialist can run tests, including AMH, FSH, LH and antral follicle count scans to give you a clearer picture of your ovarian reserve and where you may be in the transition. Acting early allows you to explore fertility options such as egg freezing or IVF while your ovaries are still producing eggs, or to plan for donor eggs if that becomes the most effective route.
At the same time, perimenopause symptoms can and should be treated, often with HRT or targeted support, so you don’t have to choose between pursuing fertility and feeling well. Taking action quickly can widen your options, reduce stress, and give you back a sense of control in what can otherwise feel like a very uncertain time.
I recall one patient in her early 40s who came to us with very low AMH. She had noticed weight gain, anxiety and irregular cycles but had been told she was “too young” for perimenopause. We explained that her symptoms were indeed early hormonal changes and combined IVF treatment with HRT support. She achieved pregnancy on her second cycle and later told me that understanding her perimenopause gave her not just a baby, but peace of mind about her health.
Another patient in her late 30s was freezing eggs after discovering a low AMH. She hadn’t yet noticed symptoms, but her bloodwork showed she was entering the earliest phase of perimenopause. By acting early, she preserved fertility options and felt more in control of her future.
These examples highlight a key truth: knowledge is power.
Perimenopause is not a separate chapter from fertility — it is the natural continuation of the same story. Understanding your ovarian reserve, your AMH level, and your symptoms allows you to plan for both family and future health.
For some women, that means pursuing IVF with low AMH. For others, it means using HRT to stabilise symptoms and protect well-being. For all women, it means being informed and supported through every stage.
At The Evewell, our mission is to ensure women don’t face these transitions alone. Whether you are trying to conceive, freezing eggs, or navigating perimenopause, we are here to guide you with compassion, expertise, and evidence-based care.
You don’t have to choose between fertility and menopause support. With the right team, you can have both.